Open Research Europe· 2026Q2
Strengthening pharmacovigilance systems through Africa-Europe collaboration: Insights from a regulatory roundtable discussion
- 0citations
- Q2SCImago
- 2026year
Short summary
An Africa-Europe roundtable identified key disparities in pharmacovigilance (PV) systems, including technology, infrastructure, human resources, and funding, while also highlighting shared goals for mutual learning and coordinated approaches.
AI-generated from the title and abstract; the full text is not read.
Key points
- African and European regulators identified common challenges in pharmacovigilance (PV) systems, including weak regulations, limited reporting culture, and reliance on paper-based systems.
- Disparities in technological capacity, infrastructure, human resources, funding, and community engagement were highlighted between the regions.
- The roundtable fostered dialogue on regulatory practices and differences in health systems, emphasizing shared values and mechanisms for mutual learning.
- Actionable recommendations were formulated to promote sustainable, collaborative, and technology-supported PV systems in Africa.
AI-generated from the title and abstract; the full text is not read.
Abstract
Background Many African countries have established national pharmacovigilance (PV) centers under their medicines regulatory authorities, but multiple barriers still limit system performance. Comprehensive, well-enforced PV regulations are often lacking, and the reporting culture among healthcare professionals and patients remains weak due to limited awareness, heavy workloads, and fear of legal consequences. The limited uptake of digital tools also leads to continued reliance on paper-based reporting, undermining data management and analysis. This manuscript summarizes an Africa–Europe roundtable where regulators discussed experiences, challenges, and priorities for strengthening PV systems. Methods The Center for Medical Ethics at the University of Oslo, in collaboration with Gispen4Regulatory Science, organized an in-person, two-day Europe-Africa roundtable discussion on June 5-6, 2025, focusing on global reflections on PV. This manuscript synthesizes discussions from a high-level Africa-Europe drug regulators, researchers and policy experts on the development and integration of PV. The roundtable brought together 30 experts for a cross-regional dialogue on drug regulation. This exchange illuminated common goals and significant asymmetries in infrastructure, capacity, and policy implementation across regions. Results The event fostered critical discussions on real-world safety monitoring, regulatory practices, and differences in health systems through short, problem-focused presentations based on active research and field practice. The roundtable discussion revealed disparities in technological and infrastructural capacity, human-resource challenges and sustainability, funding stability, community and patient engagement, and the utilization of data. It also highlighted gaps in regional harmonization, and institutional models. The study also emphasized shared values, the development of mechanisms for mutual learning and coordinated approaches. Conclusion Drawing on shared experiences, participants formulated a series of actionable recommendations aimed at fostering sustainable, collaborative, and technology- supported PV systems in Africa. The insights inform future strategies for harmonization and mutual learning within global drug safety governance.
The authors' abstract, as published at the source. Open Research Europe, 2026 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
ToxicologyPharmacology, Toxicology and Pharmaceutics